Mikael Knip, MD, DMSc; Hans K. Åkerblom, MD, DMSc; Dorothy Becker, MB, BCh; et al.
free access
JAMA. 2014;311(22):2279-2287. doi:10.1001/jama.2014.5610
In a double-blind randomized clinical trial of 2159 infants with HLA-conferred disease susceptibility and a first-degree relative with type 1 diabetes, The TRIGR Study Group tests the hypothesis that weaning to an extensively hydrolyzed formula decreases the cumulative incidence of diabetes-associated autoantibodies, May 2002-April 2013 at 78 study centers in 15 countries.
Christianne L. Roumie, MD, MPH; Robert A. Greevy, PhD; Carlos G. Grijalva, MD, MPH; et al.
free access
has multimedia
has audio
JAMA. 2014;311(22):2288-2296. doi:10.1001/jama.2014.4312
In a retrospective cohort study of veterans with diabetes initially treated with metformin, Roumie and coauthors compared time to acute myocardial infarction, stroke, or death in patients who added insulin or a sulfonylurea.
-
Podcast:
Association Between Intensification of Metformin Treatment With Insulin vs Sulfonylureas and Cardiovascular Events and All-Cause Mortality Among Patients With Diabetes
Lars Sjöström, MD, PhD; Markku Peltonen, PhD; Peter Jacobson, MD, PhD; et al.
free access
JAMA. 2014;311(22):2297-2304. doi:10.1001/jama.2014.5988
Sjöström and coauthors performed a very long-term follow-up observational study of Swedish Obese Subjects participants to investigate diabetes outcomes after bariatric surgery. They determined the long-term diabetes remission rates and the cumulative incidence of microvascular and macrovascular diabetes complications among 603 patients who had type 2 diabetes at baseline.
The SIGMA Type 2 Diabetes Consortium
free access
JAMA. 2014;311(22):2305-2314. doi:10.1001/jama.2014.6511
Florez and colleagues performed whole-exome sequencing on DNA samples from 3756 individuals of Mexican and US Latino ancestry (1794 with type 2 diabetes, 1962 controls) and identified a single low-frequency variant (pE508K) in HNF1A—the Maturity Onset Diabetes of the Young type 3 gene—associated with type 2 diabetes in this population.